Biofourmis
Private Company
Total funding raised: $470M
Overview
Biofourmis is a private, revenue-generating digital health platform company leveraging AI and machine learning to enable hospital-at-home, remote patient management, and clinical trial support. Its core offering is a technology platform that uses biosensor data and predictive analytics to improve patient outcomes, reduce costs, and support drug development. The company has over 50 global health system and payer partners, operates in 25 U.S. states, and recently merged with CopilotIQ to create an end-to-end AI-driven in-home care platform, while divesting its life science business to ActiGraph.
Technology Platform
A connected technology platform that uses wearable biosensors and AI/machine learning algorithms for remote patient monitoring, predictive analytics, and personalized care management across care settings.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Biofourmis competes in the crowded digital health and remote patient monitoring market against players like Current Health (acquired by Best Buy), Philips, Medtronic, and numerous startups. Its merger with CopilotIQ positions it against integrated providers like Contessa Health (a CVS Health company) and Signify Health, competing on the basis of its AI-driven predictive analytics platform combined with in-home clinical services.